Axon Enterprise, Inc. Stock News

Axon Enterprise (NASDAQ:AXON) had its price target reduced by equities researchers at Morgan Stanley from $200.00 to $180.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an overweight rating on the biotechnology companys stock. Morgan Stanleys price objective suggests a potential upside of 23.52% from the companys previous []

Markets remain turbulent amid inflationary pressures.

JMP Securities pumps up the volume on Axon.

JMP Securities analyst Erik Suppiger resumed coverage of Axon Enterprise Inc (NASDAQ:AXON) with an Outperform rating and a price target of $195, implying an upside of 35.7%. The analyst noted Axo

Markets remain turbulent amid inflationary pressures.

JMP Securities pumps up the volume on Axon.

The company has the know-how to make the move.

The company has the know-how to make the move.

Axon Enterprise Inc. (NASDAQ:AXON)s traded shares stood at 0.81 million during the last session, with the companys beta value hitting 0.40. At the close of trading, the stocks price was $141.45, to imply a decrease of -3.43% or -$5.02 in intraday trading. The AXON shares 52-week high remains $212.37, putting it -50.14% down since that Axon Enterprise Inc. (NASDAQ: AXON) Has Succeeded In Attracting Investors This Year, The Stock Is Up 15.44% Year-To-Date Read More »

Axon and founder Patrick Smith are riding high.

Axon and founder Patrick Smith are riding high.

The agreement, which replaces the current agreement with Axon that was approved by the council in 2017, would allow for the purchase of the Officer Safety Plan 7+ package, which includes body-worn and vehicle-mounted cameras, conductive energy weapon, transparency-enhancing software and maintenance for all officers and fleet vehicles for the next 10 years at a cost of $4.4 million.

Could an FTC suit get in the company's way?

These stocks could supercharge your portfolio over the next decade.

These stocks could supercharge your portfolio over the next decade.